This site is intended for health professionals only

Injection used to treat seminoma

A common type of testicular cancer can be cured by a single jab of chemotherapy drug, researchers have said.

Carboplatin, which is often used to treat ovarian and lung cancer, can replace radiotherapy to cure early-stage seminoma, a study found.

The drug is being hailed as a "safer cure" for the cancer by experts, with fewer long-term risks.

About 40-45% of testicular cancers are early-stage seminoma and between 780 and 880 men are diagnosed with this stage of the disease each year in the UK.

In the largest-ever trial of the disease, a single carboplatin injection was used to treat 573 patients with early-stage seminoma.

The results were compared with 904 men given two or three weeks of daily radiotherapy, the current standard treatment.

Those patients given carboplatin experienced fewer side-effects and were able to get back to their normal lives quicker than the men receiving radiotherapy, the research found.

Of 573 patients given carboplatin, a total of 5% relapsed within three years. But none of the men died from their cancer following further treatment.

Dr Ben Mead, honorary senior lecturer in medical oncology at the University of Southampton's School of Medicine, who presented the study, said: "We were pleased by the results of this huge trial.

"Giving patients a carboplatin injection rather than radiotherapy is less unpleasant with fewer long-term risks."

Copyright © PA Business 2008

University of Southampton

The latest Nursing in Practicesurvey is looking at wound care. Completing the survey will take just 5minutes and the survey results will be reported in theNovember/December 2008 issue of Nursing in Practice magazine. There will also be a prize draw where four lucky winners will win £50 worth of Marks & Spencer vouchers.
Click here to take part